Uploaded June 2026 | Updated September 2026, 3 weeks ago
Roger Neel sold his SaaS company at $100M+ ARR, took three hours off, and dove straight into a health tech startup backed by Google Ventures and Dexcom.
In this conversation, Roger breaks down the full arc — from founding Mavenlink in the teeth of the 2008 financial crash, to grinding through 13 years of customer base churn, fundraising rounds, and eventually selling to PE. He also shares what he'd do completely differently if he were starting today with AI tools at his disposal to build a 9-figure business.
We get into his framework for evaluating whether a business is actually defensible (he calls it the 3 Ds), why most SaaS companies don't need a moat until they're past $10M, what really happens when you sell to a PE firm, and how a regulatory curveball nearly killed his new company Signos right before launch.
Key Takeaways
00:00 Introduction
01:06 Building A $100M Company In The AI Era
04:08 The Origin Story Of Mavenlink
07:22 The Future Of SaaS And Custom Software
10:20 The Three Ds: Demand, Differentiation, Defensibility
17:35 Why He Jumped Into Health Tech
20:23 Finding Your Actual Passion In Business
23:27 How Signos Revolutionized Continuous Glucose Monitoring
29:59 When A Regulatory Shift Breaks Your Model
36:22 Bootstrapping Vs. Raising Capital
42:37 The 13-Year Growth Arc To Exit
46:54 Going Up Market Faster With AI
52:07 Selling To PE: How The Deal Actually Works
54:33 Why Keep Raising Instead Of Selling Earlier
56:35 PE vs. IPO
57:29 Picking The Right PE Firm
01:03:40 Advice For Raising Capital Today
01:06:02 AI Tools Entrepreneurs Should Be Using
Subscribe: youtube.com/@Beyondamillion?sub_confirmation=1
Roger Neel sold his SaaS company at $100M+ ARR, took three hours off, and dove straight into a health tech startup backed by Google Ventures and Dexcom.
In this conversation, Roger breaks down the full arc — from founding Mavenlink in the teeth of the 2008 financial crash, to grinding through 13 years of customer base churn, fundraising rounds, and eventually selling to PE. He also shares what he'd do completely differently if he were starting today with AI tools at his disposal to build a 9-figure business.
We get into his framework for evaluating whether a business is actually defensible (he calls it the 3 Ds), why most SaaS companies don't need a moat until they're past $10M, what really happens when you sell to a PE firm, and how a regulatory curveball nearly killed his new company Signos right before launch.
Key Takeaways
00:00 Introduction
01:06 Building A $100M Company In The AI Era
04:08 The Origin Story Of Mavenlink
07:22 The Future Of SaaS And Custom Software
10:20 The Three Ds: Demand, Differentiation, Defensibility
17:35 Why He Jumped Into Health Tech
20:23 Finding Your Actual Passion In Business
23:27 How Signos Revolutionized Continuous Glucose Monitoring
29:59 When A Regulatory Shift Breaks Your Model
36:22 Bootstrapping Vs. Raising Capital
42:37 The 13-Year Growth Arc To Exit
46:54 Going Up Market Faster With AI
52:07 Selling To PE: How The Deal Actually Works
54:33 Why Keep Raising Instead Of Selling Earlier
56:35 PE vs. IPO
57:29 Picking The Right PE Firm
01:03:40 Advice For Raising Capital Today
01:06:02 AI Tools Entrepreneurs Should Be Using
Subscribe: youtube.com/@Beyondamillion?sub_confirmation=1
